CELEXA (nda020822)- (EQ 10MG BASE,EQ 20MG BASE,EQ 40MG BASE,EQ 60MG BASE)

Generic Name	CITALOPRAM HYDROBROMIDE	Innovator	ABBVIE
Dosage	EQ 10MG BASE,EQ 20MG BASE,EQ 40MG BASE,EQ 60MG BASE
ParaIV Filing	No	505(b)2 Filing	No
Last Patent Expiry	Expired	NCE Excl Expiry	Expired
ODE Expiry	None	NP Expiry	None
GAIN Expiry	None	Drug Complexity	No
Indication	CELEXA is a selective serotonin reuptake inhibitor (SSRI) indicated for the treatment of major depressive disorder (MDD) in adults.

Approvals and Launches

Final Approvals	Tentative Approvals	Generic Launches
11	0	8

Other Developers

Total Other Developers	1

Drugs with Suitability

Drugs with Suitability	No

Drug Pricing

	NDA			ANDA
Dosage	Weekly	Monthly	Yearly	Yearly Up	Yearly Down
EQ 10MG BASE	**	**	-	-	5
EQ 20MG BASE	**	**	-	-	5
EQ 40MG BASE	**	**	-	-	6
EQ 60MG BASE	**	**	-	-	-

Drug Sales

NDA Sales Available	Total Generic Sales Available
Yes	7

Manufacturing Details of CELEXA